March 17, 2013 /PRNewswire/ --
Cimatron Limited (NASDAQ and TASE: CIMT) announced today that it will be hosting a webinar with MoldMaking Technology magazine on cost-effective approaches to simulating and modifying mold geometry.
Many plastic parts are challenging to mold within tolerance on the first, second and sometimes third shot. A variety of factors affect the shrink and warp of the part. Owing to the traditionally high cost of simulation, many shops still opt for machining the cavity to a steel-safe condition, molding the part and then reworking the mold according to the deformation.
The webinar will explore how some tool shops have found a cost-effective means of simulation and easy modification of the mold geometry.
In particular, the webinar will demonstrate how successful tool shops can:
- utilize cost-effective CAE tools;
- employ advanced warping tools to modify geometry with a deformation compensation percentage;
- use efficient toolpaths with multiple surface offset groups to minimize CAD work;
- provide shorter lead times to their customers; and
- advertise this capability as a value added service.
The webinar will include a demonstration of key CimatronE functionality that can assist tool shops, including the new advanced warping tools that feature in the latest version of the software, CimatronE 11.
With more than 30 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.
The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for
2.5 to 5 axes milling
. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
Cimatron's shares are publicly traded on the NASDAQ exchange and the Tel Aviv Stock Exchange under the symbol CIMT. For more information, please visit Cimatron’s web site at:
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron’s plans, objectives and expected financial and operating results. The words "may," "could," "would," “will,” "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron’s ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron’s business, refer to Cimatron’s filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts